1. Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB, Slamon DJ: Antibody to HER-2/neu receptor blocks DNA repairs after cisplatin in human breast and ovarian cancer cells. Oncogene 9:1829–1838, 1994
2. Bernards R, Destree A, McKenzie S, Gordon E, Weinberg RA, Panicali D: Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector. Proc Natl Acad Sci USA 84:6854–6858, 1987
3. Disis ML, Smith JW, Murphy AE, Chen W, Cheever MA: In vitro generation of human cytolytic T-cells specific for peptides derived from the HER-2/neu protooncogene protein. Cancer Res 54:1071–1076, 1994
4. Yanuck M, Carbone DP, Pendleton CD, Tsukui T, Winter SF, Minna JD, Berzofsky JA: A mutant p53 tumor suppressor protein is a target for peptideinduced CD8+ cytotoxic T-cells. Cancer Res 53: 3257–3261, 1993
5. Abe M, Kufe D: Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene. Proc Natl Acad Sci USA 90:282–286, 1993